Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED)

NCT00818272 · clinicaltrials.gov ↗

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

BIOLOGICAL: Remicade (infliximab)

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]